Harpreet S. Dhaliwal
CIK: 0001886794
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Vaxcyte, Inc.
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Sep 8, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct7.7K shares at avg. $60.36$462K - Sep 2, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct659 shares at avg. $61.58$41K - Aug 31, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct361 shares at avg. $60.74$22K - Aug 5, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct17K shares at avg. $55.00$935K - Aug 5, 2026PCVX
Vaxcyte, Inc.
Exercise(M)Direct17K shares at avg. $24.79$421K - Mar 9, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct604 shares at avg. $59.32$36K - Mar 2, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct465 shares at avg. $61.98$29K - Feb 28, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct292 shares at avg. $61.98$18K - Feb 26, 2026PCVX
Vaxcyte, Inc.
Award(A)Direct53.4K shares- - Dec 31, 2025PCVX
Vaxcyte, Inc.
Sale(S)Direct9.7K shares at avg. $46.69$455K - Sep 8, 2025PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct1.2K shares at avg. $32.41$39K - Sep 2, 2025PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct464 shares at avg. $31.56$15K - Sep 2, 2025PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct783 shares at avg. $31.56$25K - Sep 2, 2025PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct291 shares at avg. $31.56$9K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 7,651 | $60.36 | $461,814 | Direct |
| Sep 2, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 659 | $61.58 | $40,581 | Direct |
| Aug 31, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 361 | $60.74 | $21,927 | Direct |
| Aug 5, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 17,000 | $55.00 | $935,068 | Direct |
| Aug 5, 2026 | PCVX Vaxcyte, Inc. | Exercise(M) | 17,000 | $24.79 | $421,430 | Direct |
| Mar 9, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 604 | $59.32 | $35,829 | Direct |
| Mar 2, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 465 | $61.98 | $28,821 | Direct |
| Feb 28, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 292 | $61.98 | $18,098 | Direct |
| Feb 26, 2026 | PCVX Vaxcyte, Inc. | Award(A) | 53,409 | - | $0 | Direct |
| Dec 31, 2025 | PCVX Vaxcyte, Inc. | Sale(S) | 9,743 | $46.69 | $454,891 | Direct |
| Sep 8, 2025 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 1,204 | $32.41 | $39,022 | Direct |
| Sep 2, 2025 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 464 | $31.56 | $14,644 | Direct |
| Sep 2, 2025 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 783 | $31.56 | $24,711 | Direct |
| Sep 2, 2025 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 291 | $31.56 | $9,184 | Direct |
1-14 of 14 transactions
About Dhaliwal Harpreet S.
Dhaliwal Harpreet S. (SEC CIK 0001886794) files insider reports with the SEC as Chief Technical Ops Officer of Vaxcyte, Inc. (PCVX).
Signal8 holds 9 ownership filings by Dhaliwal Harpreet S. (1 Form 3, 8 Form 4), filed between Apr 25, 2025 and Sep 9, 2026. Those filings report 14 transactions, from Sep 2, 2025 to Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dhaliwal Harpreet S.'s filings is in SAN CARLOS, CA.
Recent filings by Dhaliwal Harpreet S.
- Sep 8, 2026: Tax withholding of PCVX shares (Form 4, code F).
- Sep 2, 2026: Tax withholding of PCVX shares (Form 4, code F).
- Aug 31, 2026: Tax withholding of PCVX shares (Form 4, code F).
- Aug 5, 2026: Open-market sale of PCVX shares (Form 4, code S).
- Aug 5, 2026: Option exercise of PCVX shares (Form 4, code M).
Other insiders filing for Vaxcyte, Inc. (PCVX)
- Wassil Jim, EVP, Chief Scientific Ofc, COO
- Cowan Elvia, SVP, Finance & CAO
- PICKERING GRANT, CHIEF EXECUTIVE OFFICER
- GUGGENHIME ANDREW, PRESIDENT AND CFO
- Jodar Luis, Chief Medical Officer
- Markels John, Director